Inhibitor Therapeutics (INTI) Stock Chart & Stock Price History $0.05 0.00 (0.00%) As of 07/3/2025 Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Inhibitor Therapeutics Stock Price Performance The Inhibitor Therapeutics (INTI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 40.00%, with a year-to-date return of -20.13%. In the past month, the stock has decreased 11.11%, reflecting recent market activity. As of the latest close, Inhibitor Therapeutics traded at $0.05 with a market cap of $8.28 million and volume of 1,500 shares. Five years ago, the stock traded at $0.07, representing a 30.43% decrease over that period. At the time, it had a market cap of $16.67 million and a volume of 1,300 shares. Receive INTI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibitor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+14.83%1 Month Performance-11.11%3 Month Performance+3.23%Year-To-Date Performance-20.13%1 Year Performance-40.00%5 Year Performance-30.43% INTI Stock Chart for Sunday, July, 6, 2025 INTI Chart by TradingView Inhibitor Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$0.05$0.05$0.05$0.051,500 shs$8.28 million07/03/2025$0.05$0.05$0.05$0.051,500 shs$8.28 million07/02/2025$0.04$0.05+14.83%$0.05$0.051,500 shs$8.28 million07/01/2025$0.04$0.04$0.04$0.043,300 shs$7.21 million06/30/2025$0.05$0.04-10.87%$0.04$0.043,300 shs$7.21 million06/27/2025$0.05$0.05-2.09%$0.05$0.044,000 shs$8.09 million06/26/2025$0.04$0.05+10.37%$0.05$0.051,000 shs$8.27 million06/20/2025$0.04$0.04$0.04$0.0433,900 shs$7.49 million06/19/2025$0.04$0.04$0.04$0.0433,900 shs$7.49 million06/18/2025$0.05$0.04-10.60%$0.04$0.0433,900 shs$7.49 million Get the Latest News and Ratings for INTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibitor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/13/2025$0.05$0.05$0.05$0.0524,250 shs$8.37 million06/12/2025$0.05$0.05-2.61%$0.05$0.0524,250 shs$8.37 million06/11/2025$0.05$0.05+8.26%$0.05$0.052,000 shs$8.59 million06/10/2025$0.05$0.05-14.81%$0.05$0.0416,843 shs$7.94 million06/09/2025$0.05$0.05$0.05$0.0510 shs$9.32 million06/06/2025$0.05$0.05$0.05$0.046,350 shs$9.32 million06/05/2025$0.05$0.05+8.00%$0.05$0.046,350 shs$9.32 million Related Companies Rein Therapeutics Stock Chart Provectus Biopharmaceuticals Stock Chart Kezar Life Sciences Stock Chart Avenir Wellness Solutions Stock Chart Marinus Pharmaceuticals Stock Chart Dyadic International Stock Chart Allakos Stock Chart Rani Therapeutics Stock Chart MiNK Therapeutics Stock Chart IntelGenx Technologies Stock Chart Receive INTI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibitor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:INTI) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibitor Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibitor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INTI Stock Alerts